These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23898080)

  • 1. Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.
    Wozniak M; Szulawska-Mroczek A; Hartman ML; Nejc D; Czyz M
    Anticancer Res; 2013 Aug; 33(8):3205-12. PubMed ID: 23898080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
    Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
    J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells.
    Wu J; Harris NL; Inge TH
    J Surg Res; 2004 Dec; 122(2):231-9. PubMed ID: 15555623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.
    Bellarosa D; Binaschi M; Maggi CA; Goso C
    Anticancer Res; 2005; 25(3B):2119-28. PubMed ID: 16158953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.
    Czyz M; Lesiak-Mieczkowska K; Koprowska K; Szulawska-Mroczek A; Wozniak M
    Br J Pharmacol; 2010 Jul; 160(5):1144-57. PubMed ID: 20590608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair.
    Mendonca MS; Chin-Sinex H; Gomez-Millan J; Datzman N; Hardacre M; Comerford K; Nakshatri H; Nye M; Benjamin L; Mehta S; Patino F; Sweeney C
    Radiat Res; 2007 Dec; 168(6):689-97. PubMed ID: 18088190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.
    Watson C; Miller DA; Chin-Sinex H; Losch A; Hughes W; Sweeney C; Mendonca MS
    Radiat Res; 2009 Apr; 171(4):389-96. PubMed ID: 19397439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parthenolide enhances dacarbazine activity against melanoma cells.
    Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
    Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitization by parthenolide in human lung adenocarcinoma A549 cells and p53- and hsp72-independent apoptosis induction via the nuclear factor-kappaB signal pathway.
    Hayashi S; Hatashita M; Hayashi A; Matsumoto H; Shioura H; Kitai R
    Int J Mol Med; 2008 May; 21(5):585-92. PubMed ID: 18425350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
    Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
    Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation.
    Tsolmongyn B; Koide N; Odkhuu E; Haque A; Naiki Y; Komatsu T; Yoshida T; Yokochi T
    Cell Immunol; 2013 Apr; 282(2):100-5. PubMed ID: 23770718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
    Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG
    Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
    Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
    Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells.
    D'Anneo A; Carlisi D; Lauricella M; Emanuele S; Di Fiore R; Vento R; Tesoriere G
    J Cell Physiol; 2013 May; 228(5):952-67. PubMed ID: 22688575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
    Fang LJ; Shao XT; Wang S; Lu GH; Xu T; Zhou JY
    Planta Med; 2010 Feb; 76(3):258-64. PubMed ID: 19774508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells.
    Kishida Y; Yoshikawa H; Myoui A
    Clin Cancer Res; 2007 Jan; 13(1):59-67. PubMed ID: 17200339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
    Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitization of tumor cells: inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin.
    Hao H; Zhou HS; McMasters KM
    Methods Mol Biol; 2009; 542():301-13. PubMed ID: 19565909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.